Literature DB >> 12582011

NPY ablation in C57BL/6 mice leads to mild obesity and to an impaired refeeding response to fasting.

Gabriella Segal-Lieberman1, Daniel J Trombly, Viral Juthani, Xiaomei Wang, Eleftheria Maratos-Flier.   

Abstract

Neuropeptide Y (NPY) is an orexigenic (appetite-stimulating) peptide that plays an important role in regulating energy balance. When administered directly into the central nervous system, animals exhibit an immediate increase in feeding behavior, and repetitive injections or chronic infusions lead to obesity. Surprisingly, initial studies of Npy(-/-) mice on a mixed genetic background did not reveal deficits in energy balance, with the exception of an attenuation in obesity seen in ob/ob mice in which the NPY gene was also deleted. Here, we show that, on a C57BL/6 background, NPY ablation is associated with an increase in body weight and adiposity and a significant defect in refeeding after a fast. This impaired refeeding response in Npy(-/-) mice resulted in a deficit in weight gain in these animals after 24 h of refeeding. These data indicate that genetic background must be taken into account when the biological role of NPY is evaluated. When examined on a C57BL/6 background, NPY is important for the normal refeeding response after starvation, and its absence promotes mild obesity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12582011     DOI: 10.1152/ajpendo.00491.2002

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  21 in total

1.  Regulation of hunger-driven behaviors by neural ribosomal S6 kinase in Drosophila.

Authors:  Qi Wu; Yan Zhang; Jie Xu; Ping Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-06       Impact factor: 11.205

Review 2.  To subjugate NPY is to improve the quality of life and live longer.

Authors:  Satya P Kalra; Pushpa S Kalra
Journal:  Peptides       Date:  2007-01-09       Impact factor: 3.750

Review 3.  Hungry for life: How the arcuate nucleus and neuropeptide Y may play a critical role in mediating the benefits of calorie restriction.

Authors:  Robin K Minor; Joy W Chang; Rafael de Cabo
Journal:  Mol Cell Endocrinol       Date:  2008-11-11       Impact factor: 4.102

Review 4.  Counterregulation of insulin by leptin as key component of autonomic regulation of body weight.

Authors:  Katarina T Borer
Journal:  World J Diabetes       Date:  2014-10-15

5.  Peroxisome proliferator-activated receptor γ controls ingestive behavior, agouti-related protein, and neuropeptide Y mRNA in the arcuate hypothalamus.

Authors:  John T Garretson; Brett J W Teubner; Kevin L Grove; Almira Vazdarjanova; Vitaly Ryu; Timothy J Bartness
Journal:  J Neurosci       Date:  2015-03-18       Impact factor: 6.167

6.  NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways.

Authors:  Kristen R Vella; Preeti Ramadoss; Francis S Lam; Jamie C Harris; Felix D Ye; Paul D Same; Nicholas F O'Neill; Eleftheria Maratos-Flier; Anthony N Hollenberg
Journal:  Cell Metab       Date:  2011-11-17       Impact factor: 27.287

7.  Mediobasal hypothalamic p70 S6 kinase 1 modulates the control of energy homeostasis.

Authors:  Clémence Blouet; Hiraku Ono; Gary J Schwartz
Journal:  Cell Metab       Date:  2008-12       Impact factor: 27.287

8.  Pioglitazone treatment increases food intake and decreases energy expenditure partially via hypothalamic adiponectin/adipoR1/AMPK pathway.

Authors:  P G F Quaresma; N Reencober; T M Zanotto; A C Santos; L Weissmann; A H B de Matos; I Lopes-Cendes; F Folli; M J A Saad; P O Prada
Journal:  Int J Obes (Lond)       Date:  2015-07-31       Impact factor: 5.095

9.  Disruption of the RIIbeta subunit of PKA reverses the obesity syndrome of Agouti lethal yellow mice.

Authors:  Traci A Czyzyk; Maria A Sikorski; Linghai Yang; G Stanley McKnight
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-02       Impact factor: 11.205

Review 10.  Critical determinants of hypothalamic appetitive neuropeptide development and expression: species considerations.

Authors:  B E Grayson; P Kievit; M S Smith; K L Grove
Journal:  Front Neuroendocrinol       Date:  2009-10-12       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.